DRUGS MADE IN AMERICA ACQUIS (DMAA) Stock Analyst Ratings

NASDAQ:DMAA • KYG2847J1040

10.43 USD
-0.02 (-0.19%)
Last: Feb 18, 2026, 08:25 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

No Analyst data available for DMAA.

Related screens

Up and Down Grades

DRUGS MADE IN AMERICA ACQUIS / DMAA FAQ